Try our Advanced Search for more refined results

Verinata Health, Inc. et al v. Ariosa Diagnostics, Inc et al

  1. September 05, 2017

    Illumina Blasts Ariosa's $100M Counterclaim In Patent Suit

    Genomics company Illumina Inc. accused rival Ariosa Diagnostics Inc. on Friday of violating California's anti-SLAPP law by bringing $100 million in counterclaims in Illumina's patent infringement suit, while Ariosa argued for its part Friday that its prenatal testing services plainly did not infringe.

  2. January 27, 2017

    Illumina Urges Fed. Circ. To Broaden Reach Of AIA Estoppel

    Illumina Inc. asked the Federal Circuit Friday to clarify which invalidity arguments the inter partes review estoppel provision bars petitioners from raising in litigation after a patent is reviewed, saying district judges have made "clear and indisputable" errors in allowing too many arguments.

  3. January 23, 2017

    Judge Allows Ariosa Invalidity Arguments From AIA Petition

    A California federal judge has allowed Ariosa Diagnostics Inc. to argue that Illumina Inc. prenatal test patents are invalid on grounds Ariosa included in an inter partes review petition but on which review was not instituted, taking a narrow reading of the America Invents Act's estoppel provision.

  4. November 19, 2014

    Ariosa Gets Stanford DNA Test Patent Nixed In AIA Review

    The Patent Trial and Appeal Board on Wednesday invalidated a prenatal DNA test patent owned by Stanford University in a victory for accused infringer Ariosa Diagnostics, weeks after the board upheld the validity of a second patent at issue in the same suit against Ariosa.

  5. February 21, 2013

    LabCorp Ducks Some Stanford Claims In Prenatal Test IP Row

    Laboratory Corporation of America Holdings partially ducked claims that it infringed Verinata Health Inc. and Stanford University's patents on prenatal tests, but it remains on the hook for claims that it indirectly infringed by taking blood for the tests, a California federal judge ruled Wednesday.

  6. October 29, 2012

    Stanford, Prenatal Blood Test Co. Say Rival Infringes Patent

    Stanford University's board of trustees and Verinata Health Inc. sued prenatal blood test maker Ariosa Diagnostics in California federal court Wednesday, alleging the company's Harmony prenatal test for Down syndrome and other fetal chromosomal disorders infringes a Stanford patent.